DexCom

Youtube Subscribe

Open: 119.26 Close: 121.34 Change: 2.08

Stop reading the whole internet to decide if you want to invest in DexCom Company Inc Stock.

How much time have you spent trying to decide whether investing in DexCom? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about DexCom are: Dexcom, G6, …

Concept Map

Semantic Network

Stock Summary

DexCom, Inc. focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems. The company provides its systems for use by people with diabetes, as well as for use. Dexcom G6.

Today's Summary

Dexcom (DXcm) stock price, quote, news & analysis - tipranks.com. The Dexcom stock analysis is based on the TipRanks Smart Score.

Today's News

Dexcom (DXcm) stock price, quote, news & analysis - tipranks.com.com. The Dexcom stock analysis is based on the TipRanks Smart Score. CB Insights Intelligence Analysts have mentioned Dexcom in 3 CBInsights research briefs, most recently on Jan 27, 2023. Dexcom is included in 3 Expert Collections, including Diabetes. DexCom stock has gained 122% since 2019 primarily due to favorable change in revenues. Analysts covering DexCom currently have a consensus Earnings Per Share forecast of $1.07 for the next financial year. DexCom (NASDAQ:DXCM – Get Rating ) last released its quarterly earnings results on Thursday, April 27th. DexCom expects full-year revenue in the range of $3.4 billion to $3 billion. Dexcom G6 Real-Time CGM System now accessible to any eligible client managing diabetes with insulin through NIHB. The Non-Insured Health Benefits (NIHB) program establishes exemplary coverage for Dexcoms real-time continuous glucose monitoring system. Dexcom G6 Real-Time CGM System now Accessible to Any Eligible Client Managing Diabetes With Insulin through NIHB program. As of April 25, 2023, any client managing diabetes with insulin can access Dexcom. Dexcom expects full-year revenue in the range of $3.4 billion to $3.52 billion. Garmin glucose level tracking app rolls out but with caveats. Garmin’s Dexcom Connect IQ app is available for various Garmin smartwatches. Dexcom (DXCM) Gets a Buy from Bernstein. Bernstein initiated coverage with a Buy rating on Dexcom. Bernstein analyst Lee Hambright covers the Healthcare sector, focusing on stocks such as Johnson & Johnson, Abbott Labs, and Dexcom. Dexcom expects full-year revenue in the range of $3.4 billion to $3.52 billion. Users recommendation: You are testing this product. Dexcom g6 picks up coverage expansion in Canada. Dexcom said its G6 CGM is now at its most accessible point ever under NIHB program. Dexcom G7 sensor is a small sensor that comes with a small overpatch. One sensor (vs separate sensor and transmitter) is smaller than the G6. Dexcom G6 sensors and transmitters can save as much $200 per 30-day supply of sensors, and an additional $200 on each 3-month transmitter. BTIG reaffirms their buy rating on Dexcom (DXCM) DexCom last released its quarterly earnings data on Thursday, February 9th where they reported earnings per share (EPS) of $0.34 for the quarter, beating consensus estimates by $0.08. The companys products include the Dexcom G6 CGM System, DexCom G6. System for Medicare, Software and Mobile apps. Dexcom (DXCM) lagged the most bullish expectations for its adjusted first-quarter earnings, but offered an otherwise broad beat. Robinhood gives you the tools you need to put your money in motion.

Stock Profile

"DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices for specific and permitted use cases, including non-medical device applications, medical device data analysis, integrated continuous glucose monitoring systems (iCGM) secondary display alarms, active patient monitoring, and treatment decisions; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California."

Keywords

The game is changing. There is a new strategy to evaluate DexCom fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about DexCom are: Dexcom, G6, DexCom, sensor, stock, revenue, earnings, and the most common words in the summary are: dexcom, stock, price, share, market, dxcm, earnings, . One of the sentences in the summary was: The Dexcom stock analysis is based on the TipRanks Smart Score.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #dexcom #stock #price #share #market #dxcm #earnings.

Read more →

Youtube Subscribe

---